NCT00802698

Brief Summary

The purpose of this study is to describe the effect of transcorneal electrical stimulation (TES) with a non conventional biphasic bipolar waveform in central retinal artery occlusion

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2008

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2008

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2008

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

Same day

First QC Date

December 3, 2008

Last Update Submit

May 29, 2024

Conditions

Central Retinal Artery Occlusion

Keywords

Biphasic waveformCentral retinal artery occlusionTo describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveformin central retinal artery occlusion

Outcome Measures

Primary Outcomes (1)

  • Visual acuity

    Baseline, Final

Study Arms (1)

Group 1

EXPERIMENTAL
Device: Transcorneal electric stimulationDevice: Transcorneal stimulation

Interventions

transcorneal electric stimulationDEVICE

central artery occlusion

Also known as: TES
Group 1
Transcorneal stimulationDEVICE

new waveform

Also known as: TES
Group 1

Eligibility Criteria

Age50 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • central retinal Artery occlusion
  • no retinal diseases associated
  • visual acuity in other eye better than 20/200

You may not qualify if:

  • Branch retinal artery occlusion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APEC

México, 04030, Mexico

Location

MeSH Terms

Conditions

Retinal Artery Occlusion

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Miriam Jessica Lopez-Miranda, MD

    Asociación para Evitar la Ceguera en México

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2008

First Posted

December 5, 2008

Study Start

April 1, 2008

Primary Completion

April 1, 2008

Study Completion

April 1, 2008

Last Updated

May 30, 2024

Record last verified: 2024-05

Locations

ME(1)